Resilience to aging is a heterogeneous characteristic defined by physical stressors.

Physical resilience, the capacity to respond to and recover from a stressful event, declines with advancing age. Individuals respond differently to physical stressors across their lifespans. While the biological underpinnings of resilience remain unclear, a plausible determinant is the capacity of an individual's cellular and molecular levels to return to homeostasis after a physical challenge. Impaired resilience may not only be a consequence of aging but could also be a contributing factor to the aging process. Therefore, resilience at relatively younger ages could be predictive of future health and lifespan. By utilizing standardized physical challenges and measuring stress response patterns, the relative resilience of individuals can be quantified and classified. Current preclinical research suggests that several physical stressors could be used to measure resilience in clinical aging studies. A mechanistic understanding of why some individuals are more resilient to physical stressors than others could help identify protective factors and therapeutic ways to promote healthy aging.

[1]  W. Ladiges,et al.  Development of a cyclophosphamide stress test to predict resilience to aging in mice , 2020, GeroScience.

[2]  Jinzi Wu,et al.  Adverse neurological effects of short-term sleep deprivation in aging mice are prevented by SS31 peptide , 2020, bioRxiv.

[3]  M. Snyder,et al.  Heterogeneity in old fibroblasts is linked to variability in reprogramming and wound healing , 2019, Nature.

[4]  R. Houtkooper,et al.  From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs , 2019, EMBO molecular medicine.

[5]  Junyang Jung,et al.  Mitophagy links oxidative stress conditions and neurodegenerative diseases , 2019, Neural regeneration research.

[6]  M. Hipp,et al.  The proteostasis network and its decline in ageing , 2019, Nature Reviews Molecular Cell Biology.

[7]  M. Evans,et al.  Circulating levels of monocyte chemoattractant protein‐1 as a potential measure of biological age in mice and frailty in humans , 2017, Aging cell.

[8]  W. Ladiges,et al.  The potential use of physical resilience to predict healthy aging , 2017, Pathobiology of aging & age related diseases.

[9]  L. Niedernhofer,et al.  The Clinical Potential of Senolytic Drugs , 2017, Journal of the American Geriatrics Society.

[10]  N. LeBrasseur Physical Resilience: Opportunities and Challenges in Translation. , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

[11]  F. Sierra,et al.  Resilience in Aging Mice. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[12]  Bing Zhang,et al.  Leveraging the complementary nature of RNA‐Seq and shotgun proteomics data , 2014, Proteomics.

[13]  P. Mishra,et al.  Stress induced premature senescence : a new culprit in ovarian tumorigenesis? , 2014, The Indian journal of medical research.

[14]  S. Berger,et al.  Epigenetics of aging and aging-related disease. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.